Rein Therapeutics (RNTX) EPS (Basic) (2016 - 2026)
Rein Therapeutics (RNTX) posted quarterly EPS (Basic) of -$0.18 for Q1 2026, up 38.99% year-over-year from -$0.13 in Q1 2025, and up 85.82% quarter-over-quarter from -$1.29 in Q4 2025.
Rein Therapeutics (RNTX) EPS (Basic) (2016 - 2026) Analysis & Trends
Rein Therapeutics (RNTX) has reported EPS (Basic) for 11 consecutive years, with -$0.18 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 38.99% year-over-year to -$0.18; the TTM figure through Mar 2026 stood at -$1.69 (up 63.17% YoY), while the FY2025 annual figure was -$1.99, up 56.4% from the prior year.
- EPS (Basic) grew to -$0.18 in Q1 2026 per RNTX's latest filing, from -$1.29 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.18 in Q1 2026 and bottomed at -$18.09 in Q4 2022.
- Historically, EPS (Basic) has averaged -$2.36 across 5 years, with a median of -$1.1 in 2023.
- Annual changes were most pronounced in 2024 — EPS (Basic) plunged 76.74% — and 2025, when it soared 84.55%.
- Rein Therapeutics' EPS (Basic) stood at -$18.09 in 2022, then soared by 68.98% to -$5.61 in 2023, then climbed by 27.21% to -$4.08 in 2024, then surged by 68.43% to -$1.29 in 2025, then soared by 85.82% to -$0.18 in 2026.
- Business Quant data shows RNTX's EPS (Basic) at -$0.18 in Q1 2026, -$1.29 in Q4 2025, and -$0.21 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.18 |
| 10 | Rein Therapeutics | 55.73 Mn | 55.73 Mn | - | -0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.10 |
| Mar 31, 2026 | -0.18 |
| Dec 31, 2025 | -1.29 |
| Sep 30, 2025 | -0.21 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -4.08 |
| Sep 30, 2024 | -0.44 |
| Jun 30, 2024 | -0.57 |
| Mar 31, 2024 | -1.94 |
| Dec 31, 2023 | -5.61 |
| Sep 30, 2023 | -0.44 |
| Jun 30, 2023 | -0.44 |
| Mar 31, 2023 | -1.10 |
| Dec 31, 2022 | -18.09 |
| Sep 30, 2022 | -1.45 |
| Jun 30, 2022 | -1.80 |
| Mar 31, 2022 | -1.89 |
| Dec 31, 2021 | -17.23 |
| Sep 30, 2021 | -1.60 |